Non-cystic Fibrosis Bronchiectasis Drug Pipeline Market 2024 Featuring Zambon, AstraZeneca, Insmed, NovaBiotics, Haisco Pharmaceutical, Armata Pharmaceuticals, Chiesi Farmaceutici, & CSL Behring
June 14, 2024 06:00 ET
|
Research and Markets
Dublin, June 14, 2024 (GLOBE NEWSWIRE) -- The "Non-cystic fibrosis bronchiectasis - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This "Non-cystic...
Bronchiectasis Presents a $731.5 Million Market Opportunity: Epidemiology Forecast, Current Trends, Drug Sales, Pipeline Analysis, Unmet Needs and Key Players
June 13, 2024 04:22 ET
|
Research and Markets
Dublin, June 13, 2024 (GLOBE NEWSWIRE) -- The "Bronchiectasis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034" report has been added to ...